未接受治疗的个体对胆固醇和降脂药物的认知和知识:一项横断面研究。

IF 2 3区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Patient preference and adherence Pub Date : 2025-05-13 eCollection Date: 2025-01-01 DOI:10.2147/PPA.S511454
Mehmet Kök, Feyzi Bostan, Ayşe Yacan Kök
{"title":"未接受治疗的个体对胆固醇和降脂药物的认知和知识:一项横断面研究。","authors":"Mehmet Kök, Feyzi Bostan, Ayşe Yacan Kök","doi":"10.2147/PPA.S511454","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The literature often includes studies on cholesterol perception and lipid-lowering medication (LLM) use with patients who have used or discontinued LLM for primary or secondary prevention. With the exponential rise in patients needing LLM each year, understanding their knowledge and perceptions of cholesterol and these drugs is crucial. For this reasons, we aimed to determine the perception and knowledge of treatment-naive participants about cholesterol and LLM.</p><p><strong>Patients and methods: </strong>This cross-sectional study was conducted in Turkey between August 2020 and August 2022. A self-designed online survey developed from literature sources was used to determine the level of knowledge and perception of cholesterol, LLM and influencing factors.</p><p><strong>Results: </strong>A total of 2062 respondents completed the survey, which was sent to the participants via an online link. The most common sources of information about cholesterol and lipid-lowering medications were medical staff (71%) media (58.4%) and scientific publications (33.3%). The most three common factors affecting the participants' perception of cholesterol and LLM were medical staff (49.6%), media (23.7%), and scientific publications (15.6%).</p><p><strong>Conclusion: </strong>Our study revealed that participants have some inaccurate and incomplete information about cholesterol and LLM. Medical staff and the media emerged as the primary sources of information and crucial influences on most participants' perceptions of cholesterol and LLM.</p>","PeriodicalId":19972,"journal":{"name":"Patient preference and adherence","volume":"19 ","pages":"1411-1422"},"PeriodicalIF":2.0000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12085121/pdf/","citationCount":"0","resultStr":"{\"title\":\"Perceptions and Knowledge of Cholesterol and Lipid-Lowering Medications Among Treatment-Naive Individuals: A Cross-Sectional Study.\",\"authors\":\"Mehmet Kök, Feyzi Bostan, Ayşe Yacan Kök\",\"doi\":\"10.2147/PPA.S511454\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>The literature often includes studies on cholesterol perception and lipid-lowering medication (LLM) use with patients who have used or discontinued LLM for primary or secondary prevention. With the exponential rise in patients needing LLM each year, understanding their knowledge and perceptions of cholesterol and these drugs is crucial. For this reasons, we aimed to determine the perception and knowledge of treatment-naive participants about cholesterol and LLM.</p><p><strong>Patients and methods: </strong>This cross-sectional study was conducted in Turkey between August 2020 and August 2022. A self-designed online survey developed from literature sources was used to determine the level of knowledge and perception of cholesterol, LLM and influencing factors.</p><p><strong>Results: </strong>A total of 2062 respondents completed the survey, which was sent to the participants via an online link. The most common sources of information about cholesterol and lipid-lowering medications were medical staff (71%) media (58.4%) and scientific publications (33.3%). The most three common factors affecting the participants' perception of cholesterol and LLM were medical staff (49.6%), media (23.7%), and scientific publications (15.6%).</p><p><strong>Conclusion: </strong>Our study revealed that participants have some inaccurate and incomplete information about cholesterol and LLM. Medical staff and the media emerged as the primary sources of information and crucial influences on most participants' perceptions of cholesterol and LLM.</p>\",\"PeriodicalId\":19972,\"journal\":{\"name\":\"Patient preference and adherence\",\"volume\":\"19 \",\"pages\":\"1411-1422\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-05-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12085121/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Patient preference and adherence\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/PPA.S511454\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Patient preference and adherence","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/PPA.S511454","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

目的:文献通常包括对使用或停用降脂药物(LLM)进行一级或二级预防的患者的胆固醇感知和降脂药物(LLM)使用的研究。随着每年需要LLM的患者呈指数级增长,了解他们对胆固醇和这些药物的知识和看法至关重要。出于这个原因,我们的目的是确定未接受治疗的参与者对胆固醇和LLM的认知和知识。患者和方法:本横断面研究于2020年8月至2022年8月在土耳其进行。利用文献资料自行设计的在线调查来确定胆固醇、法学硕士及其影响因素的知识和认知水平。结果:共有2062名受访者完成了调查,调查结果通过在线链接发送给参与者。关于胆固醇和降脂药物的最常见信息来源是医务人员(71%)、媒体(58.4%)和科学出版物(33.3%)。影响参与者对胆固醇和LLM认知的三个最常见因素是医务人员(49.6%)、媒体(23.7%)和科学出版物(15.6%)。结论:我们的研究揭示了参与者对胆固醇和LLM的一些不准确和不完整的信息。医务人员和媒体成为信息的主要来源,并对大多数参与者对胆固醇和LLM的看法产生关键影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Perceptions and Knowledge of Cholesterol and Lipid-Lowering Medications Among Treatment-Naive Individuals: A Cross-Sectional Study.

Purpose: The literature often includes studies on cholesterol perception and lipid-lowering medication (LLM) use with patients who have used or discontinued LLM for primary or secondary prevention. With the exponential rise in patients needing LLM each year, understanding their knowledge and perceptions of cholesterol and these drugs is crucial. For this reasons, we aimed to determine the perception and knowledge of treatment-naive participants about cholesterol and LLM.

Patients and methods: This cross-sectional study was conducted in Turkey between August 2020 and August 2022. A self-designed online survey developed from literature sources was used to determine the level of knowledge and perception of cholesterol, LLM and influencing factors.

Results: A total of 2062 respondents completed the survey, which was sent to the participants via an online link. The most common sources of information about cholesterol and lipid-lowering medications were medical staff (71%) media (58.4%) and scientific publications (33.3%). The most three common factors affecting the participants' perception of cholesterol and LLM were medical staff (49.6%), media (23.7%), and scientific publications (15.6%).

Conclusion: Our study revealed that participants have some inaccurate and incomplete information about cholesterol and LLM. Medical staff and the media emerged as the primary sources of information and crucial influences on most participants' perceptions of cholesterol and LLM.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Patient preference and adherence
Patient preference and adherence MEDICINE, GENERAL & INTERNAL-
CiteScore
3.60
自引率
4.50%
发文量
354
审稿时长
6-12 weeks
期刊介绍: Patient Preference and Adherence is an international, peer reviewed, open access journal that focuses on the growing importance of patient preference and adherence throughout the therapeutic continuum. The journal is characterized by the rapid reporting of reviews, original research, modeling and clinical studies across all therapeutic areas. Patient satisfaction, acceptability, quality of life, compliance, persistence and their role in developing new therapeutic modalities and compounds to optimize clinical outcomes for existing disease states are major areas of interest for the journal. As of 1st April 2019, Patient Preference and Adherence will no longer consider meta-analyses for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信